Huirong Pan

Long-Term Efficacy of a Hepatitis E Vaccine

Jun Zhang, Xuefeng Zhang, Shoujie Huang et al. · New England Journal of Medicine · 2015 · 369 citations · Full text

Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial

You‐Lin Qiao, Ting Wu, Rongcheng Li et al. · JNCI Journal of the National Cancer Institute · 2019 · 172 citations · Full text

Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin®

Xiao Zhang, Minxi Wei, Huirong Pan et al. · Vaccine · 2014 · 90 citations

Robust Manufacturing, Biomanufacturing, Synthetic Virology +6

Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial

Fanghui Zhao, Ting Wu, Yuemei Hu et al. · The Lancet Infectious Diseases · 2022 · 85 citations

Vaccination, Vaccine Safety, L1 Virus-like-particle Vaccine +11

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Shoujie Huang, Xuefeng Zhang, Yingying Su et al. · The Lancet · 2024 · 57 citations

Vaccination, Long-term Efficacy, Viral Hepatitis +5